CDMO News
AATec Medical and Northway Biotech Partner to Advance ATL-105 for Lung Diseases
AATec Medical GmbH and Northway Biotech have announced a partnership to develop the industrial production process for ATL-105, AATec’s lead inhaled biologic therapy for respiratory diseases. The agreement focuses on manufacturing process and analytical development for ATL-105, which is based
16 July 2025